Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2022-12-19 00:00:00 ET · period of report 2022-12-15 · accession 0001127602-22-027929 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-12-19 | 2022-12-15+ | DNA | Kelly Jason R | See remarks, Dir | S - Sale | $1.61 | -205.0K | 19.01M | -1% | -$329.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-12-15 | S | D | 103,547 | $1.61 | 19,110,242 | D | — | — | |
| 2 | Common | Class A Common Stock | 2022-12-16 | S | D | 101,426 | $1.60 | 19,008,816 | D | — | — |